The DOI matches its Crossref record; 63 of the 65 references it cites were found in a registry or an index.
The Fragile X Syndrome Protein FMRP Associates with BC1 RNA and Regulates the Translation of Specific mRNAs at Synapses
Open accessAbstract
The Fragile X syndrome, which results from the absence of functional FMRP protein, is the most common heritable form of mental retardation. Here, we show that FMRP acts as a translational repressor of specific mRNAs at synapses. Interestingly, FMRP associates not only with these target mRNAs, but also with the dendritic, non-translatable RNA BC1. Blocking of BC1 inhibits the interaction of FMRP with its target mRNAs. Furthermore, BC1 binds directly to FMRP and can also associate, in the absence of any protein, with the mRNAs regulated by FMRP. This suggests a mechanism where BC1 could determine the specificity of FMRP function by linking the regulated mRNAs and FMRP. Thus, when FMRP is not present, loss of translational repression of specific mRNAs at synapses could result in synaptic dysfunction phenotype of Fragile X patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This protein negatively regulates the translation of specific mRNAs at the synapse23,54.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [54]
In the citing paper
“Absence of FMRP leads to an increase of local protein synthesis (Figures 2 and 3), initially shown for the activity-regulated cytoskeleton protein (Arc), microtubule-associated protein 1B (Map1B), and alpha Ca 2+ /calmodulin-dependent kinase II (αCaMKII) proteins (69).”
From Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics (2012) · cites this paper as [69]
In the citing paper
“As in oligomer-exposed neurons, neurons in Fragile X ectopically overexpress Arc (Zalfa et al., 2003).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as Zalfa et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Self-citationInstability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Lyford, G. L., Yamagata, K., Kaufmann, W. E., Barnes, C. A., Sanders, L. K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Lanahan, A. A., & Worley, P. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90299-6 · Cited by 1,212
Brown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,108
Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5401 · Cited by 1,046
Self-citationFragile X mental retardation protein targets G quartet mRNAs important for neuronal function
Darnell, J. C., Jensen, K. B., Jin, P., Brown, V., Warren, S. T., & Darnell, R. B. (2001) · Cell · doi:10.1016/s0092-8674(01)00566-9 · Cited by 952
FMR1 Protein: Conserved RNP Family Domains and Selective RNA Binding
Ashley, C. T., Wilkinson, K. D., Reines, D., & Warren, S. T. (1993) · Science · doi:10.1126/science.7692601 · Cited by 752
Protein synthesis at synaptic sites on dendrites.
Steward, O., & Schuman, E. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.299 · Cited by 731
Somatodendritic expression of an immediate early gene is regulated by synaptic activity.
Link, W., Konietzko, U., Kauselmann, G., Krug, M., Schwanke, B., Frey, U., & Kuhl, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5734 · Cited by 710
Research works printed but not linked: 2
- Bakker, 1994, FMR1 knockout mice, Cell, 78, 23
- Hirst, 1995, Two new cases of FMR1 deletion associated with mental impairment, Am. J. Hum. Genet., 56, 67
Cited by
Sorted by citations
Items 101–200 of 677
Khandjian, E. W., Huot, M.-E., Tremblay, S., Davidovic, L., Mazroui, R., & Bardoni, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405398101 · Cited by 178
Soden, M. E., & Chen, L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3660-10.2010 · Cited by 181
Dendritic spine dysgenesis in autism related disorders
Phillips, M. L., & Pozzo‐Miller, L. D. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.011 · Cited by 188
Guzowski, J. F., Miyashita, T., Chawla, M. K., Sanderson, J. L., Maes, L. I., Houston, F. P., Lipa, P., McNaughton, B. L., Worley, P. F., & Barnes, C. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505519103 · Cited by 181
Local Protein Synthesis and Spine Morphogenesis: Fragile X Syndrome and Beyond
Grossman, A. W., Aldridge, G. M., Weiler, I. J., & Greenough, W. T. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1790-06.2006 · Cited by 177
Altered differentiation of neural stem cells in fragile X syndrome
Castrén, M., Tervonen, T., Kärkkäinen, V., Heinonen, S., Castrén, E., Larsson, K., Bakker, C. E., Oostra, B. A., & Åkerman, K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508995102 · Cited by 176
Self-citationhnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies
Lee, E. K., Kim, H. H., Kuwano, Y., Abdelmohsen, K., Srikantan, S., Subaran, S. S., Gleichmann, M., Mughal, M. R., Martindale, J. L., Yang, X., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1815 · Cited by 174
A Synaptic Model for Pain: Long-Term Potentiation in the Anterior Cingulate Cortex
Zhuo, M. (2007) · Molecules and Cells · doi:10.1016/s1016-8478(23)10716-3 · Cited by 173
Abnormal Striatal GABA Transmission in the Mouse Model for the Fragile X Syndrome
Centonze, D., Rossi, S., Mercaldo, V., Napoli, I., Ciotti, M. T., De Chiara, V., Musella, A., Prosperetti, C., Calabresi, P., Bernardi, G., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.008 · Cited by 171
Self-citationLing, S., Fahrner, P. S., Greenough, W. T., & Gelfand, V. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408114101 · Cited by 169
Gantois, I., Vandesompele, J., Speleman, F., Reyniers, E., D’Hooge, R., Severijnen, L.-A. W. F. M., Willemsen, R., Tassone, F., & Kooy, R. F. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.07.017 · Cited by 166
Hu, H., Qin, Y., Bochorishvili, G., Zhu, Y., Aelst, L. V., & Zhu, J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1496-08.2008 · Cited by 168
Volk, L. J., Pfeiffer, B. E., Gibson, J. R., & Huber, K. M. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2266-07.2007 · Cited by 166
Epilepsy and autism spectrum disorders: are there common developmental mechanisms?
Brooks-Kayal, A. (2010) · Brain and Development · doi:10.1016/j.braindev.2010.04.010 · Cited by 162
Gross, C., Yao, X., Pong, D. L., Jeromin, A., & Bassell, G. J. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6661-10.2011 · Cited by 161
Chen, L., Yun, S.-W., Seto, J., Liu, W., & Toth, M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00406-8 · Cited by 160
Staufen Recruitment into Stress Granules Does Not Affect Early mRNA Transport in Oligodendrocytes
Thomas, M. G., Tosar, L. M., Loschi, M., Pasquini, J. M., Correale, J. D., Kindler, S., & Boccaccio, G. L. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-06-0516 · Cited by 159
Goody, S. M. G., Baum, M. L., Paspalas, C. D., Fernandez, S. M., Carty, N., Kurup, P. K., & Lombroso, P. J. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003053 · Cited by 162
The Elegance of the MicroRNAs: A Neuronal Perspective
Kosik, K. S., & Krichevsky, A. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.08.019 · Cited by 158
Aβ Oligomer-Induced Synapse Degeneration in Alzheimer’s Disease
Wilcox, K. C., Lacor, P. N., Pitt, J. E., & Klein, W. L. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9691-4 · Cited by 159
Niere, F., Wilkerson, J. R., & Huber, K. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4650-11.2012 · Cited by 153
Psychopharmacology in fragile X syndrome—Present and future
Berry‐Kravis, E., & Potanos, K. (2004) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20007 · Cited by 151
Lee, H. Y., Ge, W., Huang, W. C., He, Y., Wang, G. X., Rowson-Baldwin, A., Smith, S. J., Jan, Y. N., & Jan, L. Y. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.033 · Cited by 153
Villacé, P. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh552 · Cited by 150
Aschrafi, A., Cunningham, B. A., Edelman, G. M., & Vanderklish, P. W. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409803102 · Cited by 148
G-Quadruplexes as pathogenic drivers in neurodegenerative disorders
Wang, E., Thombre, R., Shah, Y., Latanich, R., & Wang, J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab164 · Cited by 152
Michel, C. I., Kraft, R., & Restifo, L. L. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1102-04.2004 · Cited by 145
Annexin A2 Is a Novel RNA-binding Protein
Filipenko, N. R., MacLeod, T. J., Yoon, C.-S., & Waisman, D. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311951200 · Cited by 145
Tessier, C. R., & Broadie, K. S. (2008) · Development · doi:10.1242/dev.015867 · Cited by 147
Panja, D., Kenney, J. W., D’Andrea, L., Zalfa, F., Vedeler, A., Wibrand, K., Fukunaga, R., Bagni, C., Proud, C. G., & Bramham, C. R. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.016 · Cited by 143
Self-citationHu, G., Lou, Z., & Gupta, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107016 · Cited by 144
Fragile X mental retardation 1 gene enhances the translation of large autism-related proteins
Greenblatt, E. J., & Spradling, A. C. (2018) · Science · doi:10.1126/science.aas9963 · Cited by 139
Early developmental alterations in GABAergic protein expression in fragile X knockout mice
Adusei, D. C., Pacey, L. K. K., Chen, D., & Hampson, D. R. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.002 · Cited by 139
Zalfa, F., Adinolfi, S., Napoli, I., Kühn‐Hölsken, E., Urlaub, H., Achsel, T., Pastore, A., & Bagni, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504286200 · Cited by 141
Self-citationmRNPs, polysomes or granules: FMRP in neuronal protein synthesis
Zalfa, F., Achsel, T., & Bagni, C. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.05.010 · Cited by 138
Self-citationFerron, L., Nieto‐Rostro, M., Cassidy, J. S., & DOLPHIN, A. C. (2014) · Nature Communications · doi:10.1038/ncomms4628 · Cited by 140
Dendritic BC1 RNA in translational control mechanisms
Wang, H., Iacoangeli, A., Lin, D., Williams, K. L., Denman, R. B., Hellen, C. U. T., & Tiedge, H. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200506006 · Cited by 137
Giuffrida, R., Musumeci, S., D'Antoni, S., Bonaccorso, C. M., Giuffrida-Stella, A. M., Oostra, B. A., & Catania, M. V. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0932-05.2005 · Cited by 141
Self-citationGlutamatergic synapses in neurodevelopmental disorders
Moretto, E., Murru, L., Martano, G., Sassone, J., & Passafaro, M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.014 · Cited by 146
Strumbos, J. G., Brown, M. R., Kronengold, J., Polley, D. B., & Kaczmarek, L. K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1125-10.2010 · Cited by 135
Fxr1 knockout mice show a striated muscle phenotype: implications for Fxr1p function in vivo
Mientjes, E. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh150 · Cited by 139
Tucker, B., Richards, R. I., & Lardelli, M. T. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl422 · Cited by 133
Sensory Processing Phenotypes in Fragile X Syndrome
Rais, M., Binder, D. K., Razak, K. A., & Ethell, I. M. (2018) · ASN NEURO · doi:10.1177/1759091418801092 · Cited by 143
The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation
Lucà, R., Averna, M., Zalfa, F., Vecchi, M., Bianchi, F., Fata, G. L., Nonno, F. D., Nardacci, R., Bianchi, M., Nuciforo, P. G., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302847 · Cited by 135
Self-citationFMRP RNA targets: identification and validation
Darnell, J. C., Mostovetsky, O., & Darnell, R. B. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00144.x · Cited by 132
Hirsch, J., Lefort, V., Vankersschaver, M., Boualem, A., Lucas, A., Thermes, C., d’Aubenton-Carafa, Y., & Crespi, M. D. (2006) · PLANT PHYSIOLOGY · doi:10.1104/pp.105.073817 · Cited by 130
Molecular dissection of the events leading to inactivation of the FMR1 gene
Pietrobono, R., Tabolacci, E., Zalfa, F., Zito, I., Terracciano, A., Moscato, U., Bagni, C., Oostra, B., Chiurazzi, P., & Neri, G. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi024 · Cited by 130
Self-citationLocal protein synthesis during axon guidance and synaptic plasticity
Martin, K. C. (2004) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2004.05.009 · Cited by 129
Nalavadi, V. C., Muddashetty, R. S., Gross, C., & Bassell, G. J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5057-11.2012 · Cited by 128
A fragile balance: FMR1 expression levels
Oostra, B. A., & Willemsen, R. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg298 · Cited by 130
Self-citationDe Rubeis, S., & Bagni, C. (2010) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.09.013 · Cited by 126
Self-citationXu, K., Bogert, B. A., Li, W., Su, K., Lee, A., & Gao, F. (2004) · Current Biology · doi:10.1016/j.cub.2004.05.055 · Cited by 126
The Role of RNA Binding Proteins for Local mRNA Translation: Implications in Neurological Disorders
Thelen, M. P., & Kye, M. J. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00161 · Cited by 121
G-quartet-dependent recognition between the FMRP RGG box and RNA
Ramos, A., Hollingworth, D., & Pastore, A. (2003) · RNA · doi:10.1261/rna.5960503 · Cited by 125
Mechanism-based approaches to treating fragile X
Dölen, G., Carpenter, R. L., Ocain, T. D., & Bear, M. F. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.008 · Cited by 129
Role of Purα in targeting mRNA to sites of translation in hippocampal neuronal dendrites
Johnson, E. M., Kinoshita, Y., Weinreb, D. B., Wortman, M. J., Simon, R., Khalili, K., Winckler, B., & Gordon, J. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20806 · Cited by 124
DNA methylation 40 years later: Its role in human health and disease
Scarano, M. I., Strazzullo, M., Matarazzo, M. R., & D'Esposito, M. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20280 · Cited by 121
Ferrari, F., Mercaldo, V., Piccoli, G., Sala, C., Cannata, S. M., Achsel, T., & Bagni, C. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.11.015 · Cited by 125
Self-citationOf Men and Mice: Modeling the Fragile X Syndrome
Dahlhaus, R. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00041 · Cited by 133
Advances in the characterization of RNA‐binding proteins
Marchese, D., de Groot, N. S., Lorenzo-Gotor, N., Livi, C. M., & Tartaglia, G. G. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1378 · Cited by 123
Ray, B., Long, J. M., Sokol, D. K., & Lahiri, D. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020405 · Cited by 120
In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders
Pantazopoulos, H., & Berretta, S. (2015) · Neural Plasticity · doi:10.1155/2016/9847696 · Cited by 128
BC1 Regulation of Metabotropic Glutamate Receptor-Mediated Neuronal Excitability
Zhong, J. W., Chuang, S.-C., Bianchi, R., Zhao, W., Lee, H., Fenton, A. A., Wong, R. K. S., & Tiedge, H. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.3893-08.2009 · Cited by 120
Abnormal mGlu 5 Receptor/Endocannabinoid Coupling in Mice Lacking FMRP and BC1 RNA
Maccarrone, M., Rossi, S., Bari, M., Chiara, V. D., Rapino, C., Musella, A., Bernardi, G., Bagni, C., & Centonze, D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.19 · Cited by 120
Self-citationSpencer, C. M., Serysheva, E., Yuva‐Paylor, L. A., Oostra, B. A., Nelson, D. L., & Paylor, R. E. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl121 · Cited by 123
Self-citationAntar, L. N., & Bassell, G. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00090-4 · Cited by 116
Wang, H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh009 · Cited by 117
The MAP1B case: An old MAP that is new again
Villarroel‐Campos, D., & González-Billault, C. E. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22178 · Cited by 119
Ramos, A., Hollingworth, D., Adinolfi, S., Castets, M., Kelly, G. P., Frenkiel, T. A., Bardoni, B., & Pastore, A. (2006) · Structure · doi:10.1016/j.str.2005.09.018 · Cited by 115
Induced pluripotent stem cells: a new revolution for clinical neurology?
Mattis, V. B., & Svendsen, C. N. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70022-9 · Cited by 115
The FMR1 gene and fragile X‐associated tremor/ataxia syndrome
Brouwer, J. R., Willemsen, R., & Oostra, B. A. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30910 · Cited by 114
Self-citationThe Fragile X mental retardation protein regulates matrix metalloproteinase 9 mRNA at synapses.
Janusz, A., Miłek, J., Perycz, M., Pacini, L., Bagni, C., Kaczmarek, L., & Dziembowska, M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2207-13.2013 · Cited by 112
Self-citationMenon, R. P., Gibson, T. J., & Pastore, A. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.08.024 · Cited by 114
Genetics of dopamine receptors and drug addiction
Gorwood, P. A. P. M., Strat, Y. L., Ramoz, N., Dubertret, C., Moalic, J., & Simonneau, M. (2012) · Human Genetics · doi:10.1007/s00439-012-1145-7 · Cited by 115
Synaptic Plasticity and Translation InitiationPreprint
Klann, E., Antion, M. D., Banko, J. L., & Hou, L. (2004) · Learning & Memory · doi:10.1101/lm.79004 · Cited by 112
The FMRP regulon: from targets to disease convergence
Fernández, E., Rajan, N., & Bagni, C. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00191 · Cited by 117
Self-citationHuman FMRP contains an integral tandem Agenet (Tudor) and KH motif in the amino terminal domain
Myrick, L. K., Hashimoto, H., Cheng, X., & Warren, S. T. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu586 · Cited by 122
Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1KO Mice
Westmark, C. J., Westmark, P. R., O'Riordan, K. J., Ray, B. C., Hervey, C. M., Salamat, M. S., Abozeid, S. H., Stein, K. M., Stodola, L. A., Tranfaglia, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026549 · Cited by 110
Roles of lncRNAs in brain development and pathogenesis: Emerging therapeutic opportunities
Srinivas, T., Mathias, C., Oliveira-Mateos, C., & Guil, S. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.008 · Cited by 108
Mammalian Smaug Is a Translational Repressor That Forms Cytoplasmic Foci Similar to Stress Granules
Báez, M. V., & Boccaccio, G. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508374200 · Cited by 110
Brager, D. H., Akhavan, A. R., & Johnston, D. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.02.002 · Cited by 110
Smart, F. M., Aschrafi, A., Atkins, A. R., Owens, G. C., Pilotte, J., Cunningham, B. A., & Vanderklish, P. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04521.x · Cited by 111
Genetic manipulation of STEP reverses behavioral abnormalities in a fragile X syndrome mouse model
Goebel‐Goody, S. M., Wilson‐Wallis, E. D., Royston, S., Tagliatela, S. M., Naegele, J. R., & Lombroso, P. J. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2012.00781.x · Cited by 108
RNA-binding proteins balance brain function in health and disease
Schieweck, R., Ninkovic, J., & Kiebler, M. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00047.2019 · Cited by 111
The Emerging Field of Epitranscriptomics in Neurodevelopmental and Neuronal Disorders
Angelova, M. T., Dimitrova, D. G., Dinges, N., Lenče, T., Worpenberg, L., Carré, C., & Roignant, J. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00046 · Cited by 109
The fragile X syndrome: From molecular genetics to neurobiology
Willemsen, R., Oostra, B. A., Bassell, G. J., & Dictenberg, J. B. (2004) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20010 · Cited by 106
Self-citationRonesi, J. A., & Huber, K. M. (2008) · Science Signaling · doi:10.1126/stke.15pe6 · Cited by 107
Therapeutic Strategies in Fragile X Syndrome: From Bench to Bedside and Back
Gross, C., Hoffmann, A., Bassell, G. J., & Berry-Kravis, E. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0355-9 · Cited by 105
Therapeutic Strategies in Fragile X Syndrome: Dysregulated mGluR Signaling and Beyond
Groß, C., Berry‐Kravis, E., & Bassell, G. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.137 · Cited by 109
Cell-Type-Specific Translation Profiling Reveals a Novel Strategy for Treating Fragile X Syndrome
Thomson, S. R., Seo, S. S., Barnes, S. A., Louros, S. R., Muscas, M., Dando, O., Kirby, C., Wyllie, D. J. A., Hardingham, G. E., Kind, P. C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.013 · Cited by 100
Neuronal Autophagy and Neurodevelopmental Disorders
Lee, K., Hwang, S.-K., & Lee, J. (2013) · Experimental Neurobiology · doi:10.5607/en.2013.22.3.133 · Cited by 101
Targeted treatments for fragile X syndrome
Berry‐Kravis, E., Knox, A. T., & Hervey, C. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-011-9074-7 · Cited by 108
Fragile X syndrome: From protein function to therapy
Bagni, C., & Oostra, B. A. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36241 · Cited by 110
Self-citationBailey, D. B., Berry‐Kravis, E., Wheeler, A., Raspa, M., Merrien, F., Ricart, J., Koumaras, B., Rosenkranz, G., Tomlinson, M., von Raison, F., et al. (2015) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-015-9134-5 · Cited by 103
Deregulated mTOR-mediated translation in intellectual disability
Troca-Marín, J. A., Alves-Sampaio, A., & Montesinos, M. L. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.01.005 · Cited by 109
The Drosophila Fragile X Protein Functions as a Negative Regulator in the orb Autoregulatory Pathway
Costa, A. D. T., Wang, Y., Dockendorff, T. C., Erdjument‐Bromage, H., Tempst, P., Schedl, P. D., & Jongens, T. A. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.01.011 · Cited by 101
Co-regulation of mRNA translation by TDP-43 and Fragile X Syndrome protein FMRP
Majumder, P., Chu, J.-F., Chatterjee, B., Swamy, K. B. S., & Shen, C.-K. J. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1603-8 · Cited by 100
Emerging Roles of Long Non-Coding RNAs as Drivers of Brain Evolution
Zimmer‐Bensch, G. (2019) · Cells · doi:10.3390/cells8111399 · Cited by 98
The fragile X syndrome: exploring its molecular basis and seeking a treatment
Bardoni, B., Davidovic, L., Bensaid, M., & Khandjian, É. W. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406010751 · Cited by 106
Didiot, M.-C., Subramanian, M., Flatter, E., Mandel, J., & Moine, H. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0737 · Cited by 109
Metadata
- Authors
- Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C.
- Affiliations
- University of Rome Tor Vergata (IT)
- Erasmus MC (NL)
- Corresponding author
- Bagni, Claudia
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2003-02
- Volume
- 112
- Issue
- 3
- Pages
- 317-327
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2002364516
- Cited by
- 676
- References
- 65
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 14 · 2023: 13 · 2022: 9 · 2021: 21 · 2020: 19 · 2019: 27 · 2018: 28 · 2017: 36 · 2016: 19 · 2015: 33 · 2014: 39 · 2013: 31 · 2012: 36
- FWCI
- 26.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Lirias (submittedVersion, other-oa)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (5R01 HD 38038, R01HD038038)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- fragile X syndrome, FMRP, BC1 RNA, protein synthesis inhibition, synaptic dysfunction, intellectual disability, RNA-binding proteins
- MeSH terms
- Animals, Base Sequence, Brain, Dendrites, Fragile X Syndrome, Humans, Molecular Sequence Data, Nerve Tissue Proteins, Synaptic Transmission, Protein Binding, Ribonucleoproteins, RNA, Messenger, Synapses, Protein Biosynthesis, Tumor Cells, Cultured, Molecular Structure, Genes, Suppressor, RNA-Binding Proteins, Mice, Knockout, RNA, Small Cytoplasmic, Macromolecular Substances, Mice, Fragile X Messenger Ribonucleoprotein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review